Importantly, it is shown that ATG4B‐mediated DNA repair defects are significantly enhanced in patient‐derived acute myeloid leukemia (AML) cells and in mouse AML cells induced by MLLT3‐KMT2A overexpression. This evidence concerns the gene KMT2A and acute myeloid leukemia.